I hold both companies. Even though I also get inpatient, I do not think that Advantage’s exploratory reports will necessarily help its SP that much. What should make a major difference should be the resource estimate, the financing/final agreement with Orocobre (hopefully) and the final plans for construction/production. I have a larger investment in Orocobre and a smaller one in Advantage. I am confident that both companies will pay off and I am willing to wait.
ORE Price at posting:
$6.50 Sentiment: Buy Disclosure: Held